Voriconazole versus Micafungin for empirical antifungal therapy in patients with neutropenia and persistent fever

Authors
Category Primary study
Year 2008
INTERVENTION: Micafugin150mg iv once a day Voriconazole 6mg/kg iv twice a day on day1,followed by 4mg/kg iv twice daily CONDITION: febril neutropenia PRIMARY OUTCOME: defervesce and survival rate after two and four weeks from starting treatment INCLUSION CRITERIA: 1)fever with tempreture above 38.0 degree. 2)neutropenia(<500cells/uL)for at least 4days. 3)injectable antibacterials for at least 4days.
Epistemonikos ID: f27e15da265c2df1a225b6dd3f64d6064d598867
First added on: Aug 21, 2024